Submission Guidelines

• Deadline: December 19, 2026
• Submission: Email your abstract to Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.. Please include the curriculum vitae (CV) of the presenting author in the submission.

Abstract Guidelines

• Languages: Prepare your abstract and poster in English. GVIRF will be conducted primarily in English, with simultaneous translation into Arabic and French in the plenary sessions.
• Title: Please submit the title exactly as you wish it to be presented in the program (maximum 20 words). Ensure that the title effectively conveys the primary message of your study.
• Authors: Include all contributing authors in your abstract submission. Indicate which author will be presenting the poster.
• Structure: Abstracts should contain the following sections: Introduction, Methods, Results, and Conclusions.
• Length: 250 to 500 words

Accepted applicants will be notified by email in February 2027. Preference will be given to early-career scientists from the region and representatives from vaccine manufacturers in developing countries. Presenting authors of accepted abstracts will be invited to prepare a poster. If your abstract is accepted, GVIRF will cover travel expenses, subject to WHO travel policies.

If you have any questions, please contact Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser..

GVIRF-next

Cette ressource apparaît sur le Thème suivant:

• Forum mondial de recherche sur les vaccins et l'immunisation (GVIRF)

Cette ressource est incluse dans le tableau suivant: